I know what you mean. ...
One thing that seemed to get missed or not mentioned at the last update was the relevance of the patent application for glaucoma .....
My simple thought is that the approach / methodology that is being used in the eye programs has allowed them to discover that if it proves effective in the current trials, then the same approach would be effective in glaucoma. If that was the case then that surely opens up a huge opportunity. Or am I just being overly optimistic.
I know what you mean . ... One thing that seemed to get missed...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.050(4.17%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.15 | $146.7K | 125.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71742 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 11949 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |